Chromatin Accessibility Landscape of Human Pancreatic Ductal Adenocarcinoma (PDAC)
Demographics (3)
- AGE - Subject age (phv00487812.v1.p1)
- SEX - Subject sex (phv00487813.v1.p1)
- SEX - Biological sex (phv00487808.v1.p1)
Disease Events (1)
- TUMOR_SIZE - Tumor size (phv00487827.v1.p1)
Other (24)
- ADJUVANT - Whether subject was given adjuvant treatment (phv00487814.v1.p1)
- ADJUVANT_TYPE - Type of adjuvant treatment (phv00487815.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00487824.v1.p1)
- ASSAY_TYPE - Assay type (phv00487825.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00487807.v1.p1)
- DISEASE_FREE_SURVIVAL_072020 - Disease free survival at 07/2020 (phv00487817.v1.p1)
- EPCAM_SORT - EpCAM marker status (phv00487823.v1.p1)
- GEO_ACCESSION - GEO accession ID (phv00487821.v1.p1)
- LVI - Lymphovascular invasion (phv00487829.v1.p1)
- MARGIN_STATUS - Resection margin status (phv00487832.v1.p1)
- PNI - Perineural invasion (phv00487830.v1.p1)
- POS_LN_STATUS - Postive Lymph node status (phv00487831.v1.p1)
- RADIOTHERAPY - Whether subject was given radiotherapy treatment (phv00487816.v1.p1)
- RECURRENCE_STATUS_072020 - Recurrence status at 07/2020 (phv00487818.v1.p1)
- RECURRENCE_STATUS_092017 - Recurrence status at 09/2017 (discovery cohort) (phv00487819.v1.p1)
- SAMPLE_ID - Sample ID (phv00487822.v1.p1)
- SAMPLE_ID - Sample ID (phv00487810.v1.p1)
- SAMPLE_ID - Sample ID (phv00487820.v1.p1)
- STAGE - Tumor stage (phv00487833.v1.p1)
- SUBJECT_ID - Subject ID (phv00487811.v1.p1)
- SUBJECT_ID - Subject ID (phv00487806.v1.p1)
- SUBJECT_ID - Subject ID (phv00487809.v1.p1)
- TUMOR_DIFFERENTIATION - Tumor differentiation status (phv00487826.v1.p1)
- TUMOR_LOCATION - Tumor location (phv00487828.v1.p1)